The frequency of cerebral microbleeds increases with CHADS(2)  scores in stroke patients with non-valvular atrial fibrillation.
OBJECTIVE
Cerebral microbleeds (CMBs) are extravasations of blood from lipohyalinized or amyloid angiopathic cerebral arterioles, and the presence and numbers of CMBs are significantly associated with the development of oral anticoagulation (OA)-related intracranial haemorrhage (ICH). The aim of this study was to investigate whether there is a difference in CMBs burden according to CHADS(2)  scores or CHA(2) DS(2) -VASc scores in non-valvular atrial fibrillation (NVAF) patients.


METHODS
We included 550 ischaemic stroke patients who had NVAF and who had undergone brain magnetic resonance imaging (MRI) with gradient-recalled echo (GRE) T2 sequences from our prospective stroke registry between January 2005 and November 2011. We calculated CHADS(2)  scores and CHA(2) DS(2) -VASc scores for all patients based on their underlying cardiovascular diseases. The presence, location and number of CMBs were assessed in each patient. We also investigated whether the CMBs were actually associated with the development of ICH during follow-up.


RESULTS
The mean patient age was 70.4 ± 10.5 years, and 324 (58.9%) patients were men. One-hundred and seventy-three patients (31.5%) had CMBs detected on GRE MRI. Higher CHADS(2)  scores or CHA(2) DS(2) -VASc scores were strongly associated with the presence and number of CMBs. During follow-up of median 3.1 ± 1.6 years, the presence of CMBs was independently associated with the development of ICH, whilst the CHADS(2)  scores or CHA(2) DS(2) -VASc scores were not.


CONCLUSIONS
Considering the positive association between the presence of CMBs and OA-related ICH, our results suggest that the increase in ICH in high-risk groups during OA may be related to an increased burden of CMBs.
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
T-J
TJ
Song
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
J
J
Kim
Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea.
H S
HS
Lee
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea.
C M
CM
Nam
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
H S
HS
Nam
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
J H
JH
Heo
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Y D
YD
Kim
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D001921:Brain / Q000098:blood supply / Q000473:pathology*; D002318:Cardiovascular Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000150:complications; D008279:Magnetic Resonance Imaging; D008297:Male; D018570:Risk Assessment / Q000379:methods; D020521:Stroke / Q000150:complications* / Q000517:prevention & control
D000925:Anticoagulants